Introduction

The corpus luteum is a vital yet temporary organ that plays a crucial role in fertility during the luteal phase. An endocrine structure in females exists within the ovary once the ovarian follicle releases a mature ovum during ovulation. See Image. Anatomy of the Internal Structures of the Ovary. The secretion of hormones from the corpus luteum stops within 14 days after ovulation if the oocyte is not fertilized. It then degenerates into a scar within the ovary, known as corpus albicans. The corpus luteum's role is to maintain a uterine environment that allows for implementation and pregnancy. This occurs by the release of pregnancy-related hormones and regulation of the hypothalamic-pituitary access through inhibition of gonadotropin-releasing hormone from the hypothalamus, which in turn decreases the luteinizing hormone (LH) and follicle-stimulating hormone (FSH) released from the anterior pituitary. The primary hormone produced by the corpus luteum is progesterone, but it also produces inhibin A and estradiol. In the absence of fertilization, the corpus luteum regresses over time. A corpus luteum develops each time a woman ovulates so that she produces a corpus luteum numerous times throughout her lifetime.

Structure and Function

The structure of the corpus luteum consists of parenchymal and nonparenchymal cells. Due to the vast diversity of cell types of the corpus luteum, gap junctions play an important role in intercellular communication, allowing for the coordination of the functions of these different cell types.[1] The corpus luteum comprises follicular theca cells and follicular granulosa cells, and before becoming the corpus luteum, the follicle forms a corpus hemorrhagic. Since the corpus luteum is transient, its regulation is via interactions between stimulatory (luteotrophic) and inhibitory (luteolytic) mediators. Little is known about this topic, but studies show that prolactin is an important autotrophic hormone.[2][3]

The corpus luteum has 2 fates depending on whether there is a fertilized egg. If fertilization and implantation occur, by day 9, the syncytiotrophoblast cells of the blastocyst secrete human chorionic gonadotropin (HCG), the same hormone tested for the ascertainment of pregnancy. HCG is vital in the continuation of progesterone secretion from the corpus luteum. Progesterone is critical in maintaining the lining of the endometrium, which is necessary for the implantation and growth of the embryo. The corpus luteum is then known as the corpus luteum graviditatis. The corpus luteum does not have this job for the remainder of the pregnancy. Instead, the placenta maintains the pregnancy through progesterone secretion, and the corpus luteum degenerates around week 12. The alternate fate of the corpus luteum occurs if the egg does not undergo fertilization. It stops secreting progesterone, decays and turns into a corpus albicans. Without progesterone maintaining the endometrium, females shed the lining, resulting in menstruation.

Embryology

Oogenesis occurs in the female embryo before birth but does not complete until puberty. Therefore, an embryo does not form a corpus luteum. Once a female begins ovulating and menstruating, a corpus luteum forms in the ovary once the secondary oocyte is released from the follicle during monthly ovulation.

Blood Supply and Lymphatics

The blood supply of the mature corpus luteum is the highest per-unit tissue of any organ in the body. This is why adequate blood supply, achieved through the recruitment of blood vessels, is an essential part of corpus luteum development. This critical process involves the breakdown of the follicular basement membrane, endothelial cell proliferation and migration, and capillary lumina development. Angiogenic growth factors are vital to this process.[1][4] The ovarian artery provides branches that supply the cortex and medulla. These branches are responsible for supplying the corpus luteum within the ovary.[5]

Nerves

The ovary's suspensory ligament carries the pelvic plexus's sympathetic and parasympathetic nerves that innervate the ovaries.

Muscles

Although the corpus luteum has no muscle attachments, it affects an essential muscular pelvic organ, the uterus. As discussed previously, the corpus luteum plays an important role in producing hormones responsible for the decidualization of the endometrium. The hormones released from the corpus luteum cause the ovary to enter a luteal phase and the uterus to enter a secretory phase. During this time, the uterus prepares for the fertilized egg's implantation and growth.[6]

Physiologic Variants

It is crucial that the uterus can respond to hormones released from the corpus luteum. In some individuals, a luteal-phase dysfunction can induce a premature corpus luteum regression. This state then disrupts the ovulatory cycle. Steroidogenesis of the corpus luteum relies on the availability of cholesterol, achieved by the transference of cholesterol molecules to the site of steroid production. A dysfunction in this rate-limiting step can decrease the amount of steroid made, limiting what can be released. Steroidogenic acute regulatory protein is an integral part of this process that plays an important role in progesterone concentrations during the early and mid-luteal phases.[7] A luteal phase defect is a common cause of infertility in women. Etiologies that lead to delayed endometrial maturation associated with luteal phase dysfunction include defective corpus luteum function, disordered folliculogenesis, and abnormal luteal rescue. Weight loss, Hyperprolactinemia, stress, hyperandrogenism, and athletic training may contribute to dysfunction.[8]

Surgical Considerations

It is possible, although rare, to develop a corpus luteum cyst or hematoma. These cysts are characterized by intense endocrine activity and often produce excess progesterone. They can take up to 3 months to disappear, but they usually regress. They can enlarge and rupture, causing hemoperitoneum.[9] Patients on blood thinners may be more likely to develop a life-threatening bleed from a ruptured corpus luteum.[10]

Clinical Significance

The corpus luteum is very important clinically. What is termed luteal support involves the administration of progestins to encourage the uterine lining to support an implanted fertilized egg. These progestins complement the corpus luteum. A luteal phase defect results from the inability of the lining of the uterus to respond to hormones produced by the corpus luteum, which is a common cause of infertility. Another clinically significant topic concerning the corpus luteum is the use of oral contraceptives. Combined oral contraceptive pills contain 2 hormones, estrogen and progesterone, which suppress FSH and LH, thus inhibiting ovulation. Additionally, this suppression causes degeneration of the corpus luteum, resulting in a drop in progesterone levels, which inhibits normal implantation of the fertilized ova and placental attachment. In addition to the importance of progesterone in maintaining pregnancy, the corpus luteum also releases relaxin, which softens the pubic symphysis for parturition. Another clinically significant role of the corpus luteum is how exogenous hormones may manipulate it. The belief is that the supraphysiologic levels of steroids secreted during the luteal phase in patients undergoing IVF cause a corpus luteum dysfunction; this is because of the inhibition of LH release secondary to the secretion of these hormones that act via negative feedback actions at the hypothalamic-pituitary axis level, thus suppressing stimulation of progesterone. Exogenous progesterone or HCG can provide essential luteal support in patients undergoing IVF.[7]

Other Issues

It is essential to consider radiologic findings of the corpus luteum because they may be interpreted as pathologic findings. Differential diagnoses to consider include endometrioma, ectopic pregnancy, tubo-ovarian abscess, degeneration of a fibroid, and ovarian neoplasia. The normal radiological findings of the corpus luteum should be a thick-walled cyst with a crenulated inner margin and internal echoes with a “ring of fire” peripheral vascularity.[11]

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Reynolds LP, Redmer DA. Growth and development of the corpus luteum. J Reprod Fertil Suppl. 1999;54:181-91. [PubMed: 10692854]

2.

Bachelot A, Binart N. Corpus luteum development: lessons from genetic models in mice. Curr Top Dev Biol. 2005;68:49-84. [PubMed: 16124996]

3.

Murphy BD, Rajkumar K. Prolactin as a luteotrophin. Can J Physiol Pharmacol. 1985 Mar;63(3):257-64. [PubMed: 2985224]

4.

Smith MF, McIntush EW, Smith GW. Mechanisms associated with corpus luteum development. J Anim Sci. 1994 Jul;72(7):1857-72. [PubMed: 7928766]

5.

Hossain MI, O'Shea JD. The vascular anatomy of the ovary and the relative contribution of the ovarian and uterine arteries to the blood supply of the ovary in the guinea-pig. J Anat. 1983 Oct;137 (Pt 3)(Pt 3):457-66. [PMC free article: PMC1171839] [PubMed: 6654738]

6.

Hatcher RA, Kowal D. Birth Control. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Butterworths; Boston: 1990. [PubMed: 21250126]

7.

Devoto L, Kohen P, Muñoz A, Strauss JF. Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation. Reprod Biomed Online. 2009;18 Suppl 2:19-24. [PubMed: 19406027]

8.

Ginsburg KA. Luteal phase defect. Etiology, diagnosis, and management. Endocrinol Metab Clin North Am. 1992 Mar;21(1):85-104. [PubMed: 1576984]

9.

Lee MS, Moon MH, Woo H, Sung CK, Jeon HW, Lee TS. Ruptured Corpus Luteal Cyst: Prediction of Clinical Outcomes with CT. Korean J Radiol. 2017 Jul-Aug;18(4):607-614. [PMC free article: PMC5447636] [PubMed: 28670155]

10.

Barbuscia M, De Luca M, Ilaqua A, Cingari E, Lemma G, Querci A, Lentini M, Gorgone S. [Etiopathogenetic and clinical considerations of corpus luteum cysts]. G Chir. 2010 Mar;31(3):103-7. [PubMed: 20426922]

11.

Bonde AA, Korngold EK, Foster BR, Fung AW, Sohaey R, Pettersson DR, Guimaraes AR, Coakley FV. Radiological appearances of corpus luteum cysts and their imaging mimics. Abdom Radiol (NY). 2016 Nov;41(11):2270-2282. [PubMed: 27472937]

Disclosure: Rebecca Oliver declares no relevant financial relationships with ineligible companies.

Disclosure: Leela Sharath Pillarisetty declares no relevant financial relationships with ineligible companies.